Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €130.20 | €140.60 | 7.990% |
| Merit Medical Systems | 17 | 0 | 5 | 0 | €76.00 | €86.90 | 14.338% |
| Tenet Healthcare | 28 | 0 | 5 | 0 | €121.00 | €121.69 | 0.573% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €67.00 | €106.18 | 58.477% |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | €8.80 | €17.78 | 102.036% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.21 | €26.01 | 35.415% |
| Icon plc | 18 | 0 | 3 | 0 | €293.10 | €319.67 | 9.065% |
| LivaNova plc | 9 | 0 | 3 | 0 | €56.00 | €66.59 | 18.916% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €374.50 | €421.61 | 12.578% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €42.00 | €50.33 | 19.840% |
| Select Medical Holdings | 6 | 0 | 3 | 0 | €31.80 | €36.41 | 14.486% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| United Therapeutics | 18 | 0 | 3 | 0 | €251.50 | €288.66 | 14.776% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €101.30 | €184.92 | 82.547% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €110.00 | €116.99 | 6.357% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €137.20 | €236.30 | 72.229% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €162.00 | €215.54 | 33.048% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €108.00 | €147.62 | 36.681% |
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.00 | - | - |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €32.40 | €38.99 | 20.335% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €78.00 | €75.94 | -2.646% |
| Korian S.A. | 1 | 0 | 1 | 0 | €3.37 | - | - |
| Repligen Corp. | 13 | 0 | 1 | 0 | €160.40 | €184.76 | 15.187% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €97.94 | - | - |